Clinical trial
A Phase II Study of Pegylated Liposomal Doxorubicin, Bortezomib and Dexamethasone (DVD) for Patients With Newly Diagnosed Multiple Myeloma (MM)
NCT00742404 is registered in ClinicalTrials.gov with Oncotherapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study of Pegylated Liposomal Doxorubicin, Bortezomib and Dexamethasone (DVD) for Patients With Newly Diagnosed Multiple Myeloma (MM)
- Lead sponsor
- Oncotherapeutics
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2008
- Completion date
- Not reported
- Enrollment
- 35 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
multiple myeloma and plasma cell neoplasm